The  sleep disorder treatment Market Industry was valued at US$ 9.2 billion in 2022 and is expected to reach US$ 18 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2030.

Sleep disorders have become a significant concern globally, affecting a large population. As awareness about the importance of sleep health increases, the demand for effective treatment options is also rising. This has led to substantial growth in the sleep disorder treatment market, with a promising trajectory expected in the coming years.

The projected market value of US$ 18 billion by 2030 highlights the immense potential for growth and investment opportunities in this sector. Factors such as the rising prevalence of sleep disorders, advancements in diagnostic technologies, and the development of innovative treatment approaches are driving this upward trend.

Moreover, the increasing adoption of telemedicine and digital health solutions has further contributed to the market's expansion. These technological advancements have made it easier for individuals to access sleep disorder treatments remotely, enhancing convenience and improving patient outcomes.

Furthermore, the growing awareness among healthcare professionals and the general public about the adverse effects of untreated sleep disorders has fueled the demand for effective treatment options. Sleep disorders can have a profound impact on an individual's overall health and quality of life, leading to various physical and mental health issues. Recognizing the significance of addressing these concerns, healthcare providers are actively seeking advanced treatment solutions to meet the growing needs of their patients.

In conclusion, the sleep disorder treatment market is poised for substantial growth in the coming years, with a projected value of US$ 18 billion by 2030. This growth is driven by factors such as increasing awareness, technological advancements, and the rising prevalence of sleep disorders. As the market expands, there will be ample opportunities for investors and healthcare providers to contribute to the development of innovative and effective treatment options, ultimately improving the lives of individuals suffering from sleep disorders.


Get Sample Report @


By Disorder:

  • Insomnia 
  • Slumber apnea 
  • Narcolepsy 
  • Irritable bowel syndrome
  • disrupted circadian rhythms 
  • Sleepwalking, & night terrors
  • Others

By Treatment Type:

  • Drugs
  • Devices
  • Oral sanitizers
  • CBT-I
  • Luminous therapy
  • surgical procedures
  • Others

By end user

  • Sleep centers and hospitals
  • Homecare facilities
  • sleep facilities
  • rehabilitative facilities
  • academic and research institutions
  • Others
  • From Region

By Distribution Channel:

  • Pharmacies in hospitals
  • Pharmacies in retail
  • Online drugstores
  • Specialty hospitals
  • Direct selling
  • Using Diagnostic

Key players

The major players are Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Arbor Pharmaceuticals Inc., Aurobindo Pharma USA, Sanofi, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals, Inc., Taj Pharmaceuticals Limited, Eli Lilly and Company, Mallinckrodt, Alembic Pharmaceuticals Limited, Apotex Inc., Dr. Reddy’s Laboratories Ltd.& Other Players.

Table of Contents  


2.Research Methodology

3.Market Dynamics

4.Impact Analysis

4.1COVID-19 Impact Analysis

4.2.Impact of Ukraine- Russia war

4.3.Impact of Ongoing Recession on Major Economies

5.Value Chain Analysis

6.Porter’s 5 Forces Model

7.PEST Analysis

8.Sleep Disorder TreatmentMarket, By Disease

9.Sleep Disorder Treatment Market, By Treatment Type

10.Sleep Disorder Treatment Market, By  End User

11.Regional Analysis

12.Company Profile

13. Competitive Landscape

14. Use Case and Best Practices


Other Trending Report

Pancreatic Cancer Treatment Market Analysis 

Plasma Fractionation  Market Analysis


About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)